Aronne LJ - Search Results

1

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J; RIO-North America Study Group. Pi-Sunyer FX, et al. Among authors: aronne lj. JAMA. 2006 Feb 15;295(7):761-75. doi: 10.1001/jama.295.7.761. JAMA. 2006. PMID: 16478899 Clinical Trial.

2

Therapeutic controversy: Obesity--a modern-day epidemic.

Pi-Sunyer FX, Laferrère B, Aronne LJ, Bray GA. Pi-Sunyer FX, et al. Among authors: aronne lj. J Clin Endocrinol Metab. 1999 Jan;84(1):3-12. doi: 10.1210/jcem.84.1.5392-1. J Clin Endocrinol Metab. 1999. PMID: 9920054

3

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S. Miles JM, et al. Diabetes Care. 2002 Jul;25(7):1123-8. doi: 10.2337/diacare.25.7.1123. Diabetes Care. 2002. PMID: 12087008 Clinical Trial.

4

Obesity and pharmacologic therapy.

Thearle M, Aronne LJ. Thearle M, et al. Among authors: aronne lj. Endocrinol Metab Clin North Am. 2003 Dec;32(4):1005-24. doi: 10.1016/s0889-8529(03)00066-5. Endocrinol Metab Clin North Am. 2003. PMID: 14711072 Review.

5

Pharmacological approaches to weight reduction: therapeutic targets.

Korner J, Aronne LJ. Korner J, et al. Among authors: aronne lj. J Clin Endocrinol Metab. 2004 Jun;89(6):2616-21. doi: 10.1210/jc.2004-0341. J Clin Endocrinol Metab. 2004. PMID: 15181032 Review. No abstract available.

6

Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.

Lee M, Aronne LJ. Lee M, et al. Among authors: aronne lj. Am J Cardiol. 2007 Feb 19;99(4A):68B-79B. doi: 10.1016/j.amjcard.2006.11.007. Epub 2006 Dec 27. Am J Cardiol. 2007. PMID: 17307059 Review.

7

Therapeutic options for modifying cardiometabolic risk factors.

Aronne LJ. Aronne LJ. Am J Med. 2007 Mar;120(3 Suppl 1):S26-34. doi: 10.1016/j.amjmed.2007.01.005. Am J Med. 2007. PMID: 17320519 Review.

8

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.

Aronne L, Fujioka K, Aroda V, Chen K, Halseth A, Kesty NC, Burns C, Lush CW, Weyer C. Aronne L, et al. J Clin Endocrinol Metab. 2007 Aug;92(8):2977-83. doi: 10.1210/jc.2006-2003. Epub 2007 May 15. J Clin Endocrinol Metab. 2007. PMID: 17504894 Clinical Trial.

9

Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy.

Aronne LJ, Isoldi KK. Aronne LJ, et al. Am J Cardiol. 2007 Dec 17;100(12A):18P-26P. doi: 10.1016/j.amjcard.2007.10.010. Am J Cardiol. 2007. PMID: 18154742 Review.

10

Rimonabant: new data and emerging experience.

Wright SM, Dikkers C, Aronne LJ. Wright SM, et al. Among authors: aronne lj. Curr Atheroscler Rep. 2008 Feb;10(1):71-8. doi: 10.1007/s11883-008-0011-5. Curr Atheroscler Rep. 2008. PMID: 18366988 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page